Tag Archives: intellectual property

Congress and Trump are out of step on Intellectual Property

Posted on September 4, 2018 by Warren Woessner

This is a guest post from Russell Slifer that first appeared on The Hill (8/30/2018). The Trump administration started its trade war this year with China under the auspices of countering Beijing’s theft of U.S. intellectual property. There is no doubt … Continue reading →

Posted in Govt Policy/PTO Policy | Tagged , , , , , , , , , | 1 Comment

New Webinar Series: Practical IP for Natural Sciences

Posted on August 23, 2017 by Warren Woessner

Please join us in a new webinar series directed to the practical strategies in a new era of patent law to protect IP in chemistry, pharmaceuticals, biotechnology and genetic medicine. The collision of new technologies and patent statutes of a … Continue reading →

Posted in Webinar | Tagged , , , , , , | Leave a comment

USPTO Post-Prosecution Pilot Program Launches

Posted on July 12, 2016 by Warren Woessner

A guest post from Edward Sandor, attorney at Schwegman. The Post-Prosecution Pilot Program (P3) launched at the USPTO Monday, combining features of the AFCP 2.0 and Pre-Appeal Brief Conference Pilot programs, with the notable addition of Applicant participation in the process. … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , , , | Leave a comment

FDA Releases Outline of Guidance for Developing Tests Based on Human Genetic Variants

Posted on July 8, 2016 by Warren Woessner

The FDA is charged with regulating “Next Generation Sequencing (NGS) Tests,” and has just released draft guidance on what needs to be regulated. (A copy of the first draft and second draft can be found at the end of this … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment